| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0007 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.0008 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |